Flutavir 75 mg capsules contain oseltamivir, an antiviral medicine for influenza. It is made by Incepta Pharmaceuticals Ltd. and is available in a pack of 1 x 10 capsules.
There are 11 brands of Oseltamivir listed in Bangladesh. By unit price, Flutavir is among the cheapest of them.
What is Flutavir 75 mg Capsule?
Flutavir 75 mg is a capsule form of oseltamivir, an antiviral medicine that belongs to the group used for respiratory viral infections such as influenza. It works by blocking a viral enzyme needed for the influenza virus to spread. It is used to treat influenza in adults and children over one year of age when the virus is circulating in the community, and to prevent influenza in adults and adolescents who have been in contact with someone diagnosed with flu. The doctor decides whether it is suitable and the course of treatment.
Uses of Flutavir
Flutavir is used to treat influenza in adults and in children over one year of age when the influenza virus is circulating in the community. It is also used to help prevent influenza in adults and adolescents who have been in close contact with someone diagnosed with flu. It is not effective against illnesses caused by agents other than influenza viruses types A and B.
How to use Flutavir
Flutavir capsules may be taken with or without food; taking them with food may improve tolerability in some people. The dose, how often to take it and how long to continue are decided by the doctor. For treatment, it is usually started soon after symptoms appear, but the exact timing is set by the doctor. Do not change the dose or stop early without medical advice.
Side effects of Flutavir
The most commonly reported side effects are nausea and vomiting. These are usually mild to moderate and tend to occur during the first two days of taking the medicine. Less common side effects reported include unstable angina, anemia, pseudomembranous colitis, humerus fracture, pneumonia, fever and peritonsillar abscess. Tell your doctor if you notice any side effect or if it bothers you.
Safety and precautions
Flutavir is not suitable for people with a known allergy to any of its ingredients. There is not enough human information to judge the risk during pregnancy, so it should be used in pregnancy only if the doctor considers it necessary. It is not known whether oseltamivir passes into breast milk, so breastfeeding mothers should use it only when the doctor decides the benefit outweighs the risk. Ask your doctor before use if you are pregnant, breastfeeding, or have other health conditions.
Frequently asked questions
What is Flutavir used for and what kind of medicine is it?
Flutavir is an antiviral capsule containing oseltamivir. It is used to treat influenza in adults and children over one year when the virus is circulating, and to prevent influenza in adults and adolescents who have been in contact with someone diagnosed with flu.
How should Flutavir be taken?
Flutavir capsules can be taken with or without food. The dose, how often to take it and how long to continue are decided by your doctor. Follow the doctor's instructions and do not change the dose without asking.
Is Flutavir safe in pregnancy or breastfeeding?
There is not enough human information to judge the risk of Flutavir in pregnancy. It is not known whether the medicine passes into breast milk. Pregnant or breastfeeding women should ask the doctor before using it.
Oseltamivir is indicated for prevention of flu (influenza) in adults and adolescents aged 13 years and over who have been in contact with someone diagnosed with flu; treatment of flu (influenza) in adults and in children over one year of age when the influenza virus is circulating in the community
Pharmacology
Oseltamivir is a prodrug of oseltamivir carboxylate. Oseltamivir carboxylate inhibits neuraminidase (sialidase), a viral surface enzyme which is responsible for the replication and infectivity of influenza virus A and B, thereby preventing the release of viruses from infected cells.
Dosage & Administration
Oseltamivir Phosphate may be taken with or without food. However, when taken with food, tolerability may be enhanced in some patients.
Standard oral dose for the treatment of influenza:
Adults and Adolescents: The recommended oral dose of Oseltamivir for treatment of influenza in adults and adolescents 13 years and older is 75 mg twice daily for 5 days. Treatment should begin within 2 days of onset of symptoms of influenza.
Pediatric patients: The safety and efficacy of Oseltamivir for prophylaxis of influenza in pediatric patients younger than 13 years of age have not been established.
Recommended oral dose for the treatment of influenza:
For prophylaxis of influenza in adults and adolescents 13 years and older following close contact with an infected individual: 75 mg once daily for at least 7 days. Therapy should begin within 2 days of exposure.
For prophylaxis during a community outbreak of influenza: 75 mg once daily. Safety and efficacy have been demonstrated for up to 6 weeks. The duration of protection lasts for as long as dosing is continued.
Interaction
Information derived from pharmacology and pharmacokinetic studies of Oseltamivir suggests that clinically significant drug interactions are unlikely. Co-administration with amoxicillin does not alter plasma levels of either compound.
Contraindications
Oseltamivir is contraindicated in patients with known hypersensitivity to any of the components of the product.
Side Effects
The most frequently reported adverse events are nausea and vomiting. These events generally of mild to moderate degree and usually are occurred on the first 2 days of administration. Additional adverse events occurring in <1% of patients receiving Oseltamivir for treatment include unstable angina, anemia, pseudomembranous colitis, humerus fracture, pneumonia, pyrexia, and peritonsillar abscess.
Pregnancy & Lactation
Pregnancy Category C: There are insufficient human data upon which to base an evaluation of risk of Oseltamivir Phosphate to the pregnant woman or developing fetus.
Nursing Mothers: It is not known whether oseltamivir or oseltamivir carboxylate is excreted in human milk. Oseltamivir Phosphate should, therefore, be used only if the potential benefit for the lactating mother justifies the potential risk to the breast-fed infant.
Precautions & Warnings
There is no evidence for efficacy of Oseltamivir Phosphate in any illness caused by agents other than influenza viruses Types A and B. Efficacy of Oseltamivir Phosphate in patients who begin treatment after 40 hours of symptoms has not been established.
Overdose Effects
At present there has been no experience of over dose. Single dose of up to 1000 mg of Oseltamivir have been associated with nausea and/or vomiting.
Storage Conditions
Store at 25°C. Reconstituted susp: Store between 2-8°C for up to 17 days or at 25°C for up to 10 days. Do not freeze.
Alternative brands of Oseltamivir
Other brands with the same generic name, cheapest first.